eCTD AI Tool Overview
eCTD is a dedicated online section of the Center for Drug Evaluation (CDE) website, the drug review arm of China's National Medical Products Administration. It gathers the framework, announcements, and submission entry points connected to the electronic common technical document format used in pharmaceutical registration. The portal is aimed at regulatory affairs teams rather than general consumers, and its content is presented mainly in Chinese.
What it does
The portal centralizes information about electronic submissions for drug registration in China. Instead of hunting through scattered regulatory notices, applicants can find background material on the eCTD specification, implementation milestones, and the technical structure expected in a submission package. It functions as a reference and access point for companies preparing electronic dossiers for review.
Key capabilities
- Submission hub: Provides a starting point for electronic document delivery tied to the CDE review process.
- Standardization guidance: Explains the eCTD structure so applicants can align dossiers with the expected format.
- Regulatory updates: Publishes notices and timing information that affect when and how electronic submissions are accepted.
- Technical references: Points to specifications and validation expectations for building a compliant package.
Who it is for
The service is designed for pharmaceutical and biotech companies, contract research organizations, and regulatory consultants that file drug applications in China. It is especially relevant to regulatory operations specialists who assemble and validate eCTD sequences. Researchers looking for general drug data or patients seeking medical information are not the intended audience, though the site may link to broader CDE resources.
How to get started
- Visit the eCTD section of the CDE website through a browser; a desktop environment is recommended for reading technical documents.
- Review the introductory and specification pages to understand the submission structure and current implementation phase.
- Confirm which application types and timelines require electronic filing, since requirements may be phased in over time.
- Prepare dossiers using compliant authoring and validation software, then follow the published submission channel.
Pricing and access caveat
Access to the informational pages appears free and publicly available, and no subscription tier is advertised on the portal itself. However, details such as accepted submission channels, mandatory formats, and any related fees may change as the program develops, and some functions may require registration or a separate system. Verify current rules directly with official CDE notices before filing. Nothing on this page constitutes regulatory advice.
Comments & Questions (0)
No comments yet
Be the first to comment!